
European Startup Funding Rounds Span Biotech, Insurance and AI Security
OMass Therapeutics raises €275 million, Nauta Capital closes a new fund, and Stand and Harmonic Security secure fresh capital across Europe and the US.
AfroEuropa Newsroom
AfroEuropa desk
A series of funding announcements across Europe and the United States has drawn capital into biotech, venture investment, property insurance and enterprise AI security.
OMass Therapeutics raises €275 million
Oxford spin-out OMass Therapeutics, a UK biotech developing small-molecule treatments, closed an oversubscribed €275 million (£230 million) Series C round, according to EU-Startups. The financing was co-led by new investors Bain Capital Life Sciences, Forbion and Novo Holdings, with participation from Janus Henderson Investors, SV Health Investors and Jefferson Life Sciences. Existing backers also took part, including Syncona, Oxford Science Enterprises, GV, Northpond Ventures, Sanofi Ventures, British Business Bank and the University of Oxford.
Keep reading
UK Budget Targets Scaleup Gap as Britain Leads Europe on Startup Funding
New tax reliefs and entrepreneur support aim to keep British firms scaling at home, though experts say incentives alone will not close the scaleup gap.
Other highlights
WhatsApp Rolls Out Group Status and Message-Sharing Updates
The messaging app introduced Group Status updates visible only to group members, along with tools to share old messages with new members and pin messages.
Follow the storyOne newsletter, two continents
The Bridge brings you the tech, startups, and leaders moving between Africa and Europe in one sharp email each morning. No spam, unsubscribe anytime.












